Ankle-Brachial Index Predicts Long-Term Renal Outcomes in Acute Stroke Patients.
Tsung-Lin LeeYu-Ming ChangChi-Hung LiuHui-Chen SuPi-Shan SungSheng-Hsiang LinChih-Hung ChenPublished in: Healthcare (Basel, Switzerland) (2022)
Renal dysfunction is common after stroke. We aimed to investigate the clinical predictability of the ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV) on poststroke renal deterioration. A total of 956 consecutive participants with acute ischemic stroke between 1 July 2016, and 31 December 2017 were enrolled and a final of 637 patients were recruited for final analysis. By using the group-based trajectory model (GBTM), the patients' renal function trajectories were grouped into the low, intermediate, and high categories (LC, IC, and HC). Significant deterioration in the slope was noted in the IC ( p < 0.001) and LC ( p = 0.002) groups but was nonsignificant in the HC ( p = 0.998) group. Abnormal ABI (ABI ≤ 0.9) was independently related to LC (adjusted odds ratio: 2.40; 95% CI, 1.16-4.95; p = 0.019) and was also independently associated with increased risks of a ≥30% decline in eGFR (adjusted hazard ratio [aHR], 2.28; 95% CI, 1.29-4.05; p = 0.005), a doubling of serum creatinine (aHR, 3.60; 95% CI, 1.93-8.34; p < 0.001) and ESRD (HR, 3.28; 95% CI, 1.23-8.74; p = 0.018). However, baPWV did not have a significant relationship with any of the renal outcomes. Patients with a lower ABI during acute stroke should receive regular renal function tests and should be closely monitored to improve poststroke renal care.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- acute ischemic stroke
- prognostic factors
- small cell lung cancer
- blood pressure
- depressive symptoms
- palliative care
- oxidative stress
- adipose tissue
- risk assessment
- epidermal growth factor receptor
- pain management
- tyrosine kinase
- skeletal muscle
- patient reported outcomes
- uric acid
- upper limb